Volume | 771,065 |
|
|||||
News | - | ||||||
Day High | 0.25 | Low High |
|||||
Day Low | 0.23 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.24 | 0.23 | 0.25 | 0.2391 | 0.2365 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
226 | 771,065 | $ 0.240973 | $ 185,806 | - | 0.1275 - 0.418 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:59:46 | 120 | $ 0.2391 | USD |
CytoDyn Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
235.09M | 921.12M | 556.02M | 0 | -79.82M | -0.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CytoDyn (QB) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1829 | 0.279 | 0.1775 | 0.2202568 | 2,475,862 | 0.0562 | 30.73% |
1 Month | 0.148 | 0.279 | 0.1285 | 0.1830771 | 1,342,449 | 0.0911 | 61.55% |
3 Months | 0.2621 | 0.28 | 0.1275 | 0.1797668 | 1,720,638 | -0.023 | -8.78% |
6 Months | 0.184 | 0.418 | 0.1275 | 0.1960026 | 2,681,036 | 0.0551 | 29.95% |
1 Year | 0.252 | 0.418 | 0.1275 | 0.2017318 | 2,008,900 | -0.0129 | -5.12% |
3 Years | 2.21 | 2.54 | 0.1275 | 0.6106405 | 2,141,435 | -1.97 | -89.18% |
5 Years | 0.415 | 10.01 | 0.1275 | 2.15 | 2,885,058 | -0.1759 | -42.39% |
CytoDyn (QB) Description
CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. |